Neoadjuvant clinical trial with sorafenib for patients with stage II or higher renal cell carcinoma

C. Lance Cowey, Chirag Amin, Raj S. Pruthi, Eric M. Wallen, Matthew E. Nielsen, Gayle Grigson, Cathy Watkins, Keith V. Nance, Jeffrey Crane, Mark Jalkut, Dominic T. Moore, William Y. Kim, Paul A. Godley, Young E. Whang, Julia R. Fielding, W. Kimryn Rathmell